- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC ; volume:14 ; number:1 ; day:16 ; month:12 ; year:2014 ; pages:1-10 ; date:12.2014
BMC complementary and alternative medicine ; 14, Heft 1 (16.12.2014), 1-10, 12.2014
- Creator
-
Gostner, Johanna M.
- Contributor
-
Ganzera, Markus
Becker, Kathrin
Geisler, Simon
Schroecksnadel, Sebastian
Überall, Florian
Schennach, Harald
Fuchs, Dietmar
SpringerLink (Online service)
- DOI
-
10.1186/1472-6882-14-503
- URN
-
urn:nbn:de:1111-2016072026255
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gostner, Johanna M.
- Ganzera, Markus
- Becker, Kathrin
- Geisler, Simon
- Schroecksnadel, Sebastian
- Überall, Florian
- Schennach, Harald
- Fuchs, Dietmar
- SpringerLink (Online service)
Other Objects (12)
H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
Synthesis of an Indoleamine-2,3-dioxygenase-1 (IDO1) Inhibitor
Ligand and Substrate Migration in Human Indoleamine 2,3-Dioxygenase
Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Charakterisierung von Indoleamine 2,3-Dioxygenase-positiven CD25-positiven tolerogenen dendritischen Zellen
Indoleamine 2,3-dioxygenase and ischemic heart disease: a Mendelian Randomization study
Indoleamine 2,3-dioxygenase 1 versus Toxoplasma gondii - host species determines success
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy